Alpine Global Management, LLC Mersana Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.84 - $5.0 $28,471 - $50,125	-10,025 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.74 - $6.63 $21,744 - $38,546	-5,814 Reduced 36.71%	10,025 $40,000
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $86,797 - $156,172	15,839 New	15,839 $99,000
Q2 2021 Aug 13, 2021	SELL	$13.28 - $18.07 $141,538 - $192,590	-10,658 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$15.31 - $26.52 $163,173 - $282,650	10,658 New	10,658 $172,000

125

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $52.5M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.